Atıf İçin Kopyala
Asero R., BAVBEK S., Blanca M., Blanca-Lopez N., Cortellini G., Nizankowska-Mogilnicka E., ...Daha Fazla
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, cilt.160, sa.2, ss.126-133, 2013 (SCI-Expanded)
-
Yayın Türü:
Makale / Derleme
-
Cilt numarası:
160
Sayı:
2
-
Basım Tarihi:
2013
-
Doi Numarası:
10.1159/000342424
-
Dergi Adı:
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.126-133
-
Anahtar Kelimeler:
NSAID, Urticaria, Cross-reactivity, Oral challenge tests, COX-1, COX-2, Nonsteroidal anti-inflammatory drug hypersensitivity, NONSTEROIDAL ANTIINFLAMMATORY DRUGS, ASPIRIN-INDUCED URTICARIA, INDUCED SKIN DISORDERS, ADVERSE-REACTIONS, CYCLOOXYGENASE-2 INHIBITORS, TERM TOLERABILITY, RISK-FACTORS, INTOLERANCE, HYPERSENSITIVITY, ETORICOXIB
-
Ankara Üniversitesi Adresli:
Evet
Özet
Nonsteroidal anti-inflammatory drugs (NSAIDs) represent one of the most frequent causes of drug-induced urticaria/angioedema worldwide. Recent review articles have classified patients experiencing NSAID-induced urticaria/angioedema into different categories, including single reactors, multiple reactors, and multiple reactors with underlying chronic urticaria. Each of these categories requires a different clinical approach. The present article, written by a panel of experts, reports the main recommendations for the practical clinical management of patients with a history of urticaria/angioedema induced by multiple NSAID based on current knowledge. Copyright (c) 2012 S. Karger AG, Basel